全文获取类型
收费全文 | 20925篇 |
免费 | 2206篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 334篇 |
儿科学 | 560篇 |
妇产科学 | 528篇 |
基础医学 | 2948篇 |
口腔科学 | 515篇 |
临床医学 | 2448篇 |
内科学 | 4523篇 |
皮肤病学 | 255篇 |
神经病学 | 1415篇 |
特种医学 | 712篇 |
外科学 | 2978篇 |
综合类 | 576篇 |
一般理论 | 18篇 |
预防医学 | 2207篇 |
眼科学 | 264篇 |
药学 | 1502篇 |
中国医学 | 6篇 |
肿瘤学 | 1398篇 |
出版年
2022年 | 137篇 |
2021年 | 298篇 |
2020年 | 178篇 |
2019年 | 317篇 |
2018年 | 352篇 |
2017年 | 287篇 |
2016年 | 305篇 |
2015年 | 351篇 |
2014年 | 485篇 |
2013年 | 716篇 |
2012年 | 1061篇 |
2011年 | 1089篇 |
2010年 | 601篇 |
2009年 | 568篇 |
2008年 | 987篇 |
2007年 | 1118篇 |
2006年 | 1056篇 |
2005年 | 1073篇 |
2004年 | 988篇 |
2003年 | 1015篇 |
2002年 | 894篇 |
2001年 | 619篇 |
2000年 | 692篇 |
1999年 | 601篇 |
1998年 | 297篇 |
1997年 | 256篇 |
1996年 | 208篇 |
1995年 | 214篇 |
1994年 | 200篇 |
1993年 | 172篇 |
1992年 | 450篇 |
1991年 | 415篇 |
1990年 | 395篇 |
1989年 | 388篇 |
1988年 | 343篇 |
1987年 | 340篇 |
1986年 | 329篇 |
1985年 | 322篇 |
1984年 | 236篇 |
1983年 | 209篇 |
1982年 | 169篇 |
1981年 | 127篇 |
1979年 | 238篇 |
1978年 | 188篇 |
1977年 | 142篇 |
1976年 | 147篇 |
1975年 | 128篇 |
1974年 | 146篇 |
1973年 | 129篇 |
1972年 | 130篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
James Milligan Joseph Lee Matt Smith Lindsay Donaldson Peter Athanasopoulos Kent Bassett-Spiers 《The journal of spinal cord medicine》2020,43(2):223-233
Context: Persons with spinal cord injury (SCI) experience significant challenges when they access primary care and community services.Design: A provincial summit was held to direct research, education, and innovation for primary and community care for SCI.Setting: Toronto, Ontario, Canada.Participants: Key stakeholders (N?=?95) including persons with SCI and caregivers, clinicians from primary care, rehabilitation, and specialized care, researchers, advocacy groups, and policy makers.Methods: A one-day facilitated meeting that included guest speakers, panel discussions and small group discussions was held to generate potential solutions to current issues related to SCI care and to foster collaborative relationships to advance care for SCI. Perspectives on SCI management were shared by primary care, neurosurgery, rehabilitation, and members of the SCI communityOutcome Measures: Discussions were focused on five domains: knowledge translation and dissemination, application of best practices, communication, research, and patient service accessibility.Results: Summit participants identified issues and prioritized solutions to improve primary and community care including the creation of a network of key stakeholders to enable knowledge creation and dissemination; an online repository of SCI resources, integrated health records, and a clinical network for SCI care; development and implementation of strategies to improve care transitions across sectors; implementation of effective care models and improved access to services; and utilization of empowerment frameworks to support self-management.Conclusions: This summit identified priorities for further collaborative efforts to advance SCI primary and community care and will inform the development of a provincial SCI strategy aimed at improving the system of care for SCI. 相似文献
2.
3.
4.
5.
6.
7.
P J Hayden C J Welsh Y Yang W H Schaefer A J Ward J L Stevens 《Chemical research in toxicology》1992,5(2):232-237
Nephrotoxic cysteine conjugates derived from a variety of halogenated alkenes are enzymatically activated via the beta-lyase pathway to yield reactive sulfur-containing metabolites which bind covalently to cellular macromolecules. Mitochondria contain beta-lyase enzymes and are primary targets for binding and toxicity. Previously, mitochondrial protein and/or DNA have been considered as molecular targets for cysteine conjugate metabolite binding. We now report that metabolites of nephrotoxic cysteine conjugates form covalent adducts with rat kidney mitochondrial phospholipids. Rat kidney mitochondria were incubated with the 35S-labeled conjugates S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC), S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine (CTFC), S-(1,2-dichlorovinyl)-L-cysteine, and S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine. Quantitation of metabolite binding to whole mitochondria and to mitochondrial protein and lipid fractions revealed that as much as 42% of the 35S-label associated with the mitochondria was found in the lipid fraction. Total lipids were also extracted from 35S-treated mitochondria and separated by thin-layer chromatography. 35S-Containing metabolites were found in the lipid fractions from mitochondria treated with each of the conjugates. Lipids from both [35S]CTFC- and [35S]-TFEC-treated mitochondria contained major 35S-labeled lipid adducts which had similar mobility by thin-layer chromatography. Fatty acid analysis, 19F and 31P NMR spectroscopy, and mass spectrometric analyses confirmed that the major TFEC and CTFC adducts are thioamides of phosphatidylethanolamine. 相似文献
8.
Timothy Threlfall Neil Kent Peter Garcia-Webb Elizabeth Byrnes Paul Psaila-Savona 《Australian and New Zealand journal of public health》1993,17(4):379-381
Abstract: This study reports on an analysis of the lead concentrations in 123 venous blood samples collected from Perth children aged between two months and 17 years attending Princess Margaret Hospital. The overall geometric mean was 6.9 μg lead per 100 ml whole blood, with 95 per cent of results lying between 3.2 and 14.8 μg/100 ml. Among children under five years of age, those aged between 18 months and two years had the highest geometric mean blood lead (11.1 μg/100 ml). There were no consistent associations between geometric mean blood lead and area of residence, age group or sex. In this sample of Perth children, the mean blood lead concentration was lower than those reported in other studies. Less than 0.1 per cent of children of the age range studied would have been expected to have lead levels exceeding the NHMRC ‘level of concern’ (25 μg/100 ml) current at the time of the study. However, the recent adoption of goal of less than 10 μg/100 ml could mean that lead levels in up to 21 per cent of Perth children would now be regarded as excessive. 相似文献
9.
10.
The immunolocalisation of the neuroendocrine specific protein PGP9.5 during neurogenesis in the rat. 总被引:2,自引:0,他引:2
We have examined the immunolocalisation of the protein gene product (PGP) 9.5 during neurogenesis in the rat embryo. PGP9.5 was first present at 11.5 days gestation (E11.5): all morphologically recognisable nerve cell bodies and fibres were immunoreactive. In routinely processed, wax-embedded tissues, using a standard immunocytochemical technique, PGP9.5 polyclonal antibody specifically demonstrated the developing nervous system and primitive adrenal chromaffin cells. 相似文献